BE840253A - Compose utilisables dans le traitement des infections bacteriennes - Google Patents
Compose utilisables dans le traitement des infections bacteriennesInfo
- Publication number
- BE840253A BE840253A BE165741A BE165741A BE840253A BE 840253 A BE840253 A BE 840253A BE 165741 A BE165741 A BE 165741A BE 165741 A BE165741 A BE 165741A BE 840253 A BE840253 A BE 840253A
- Authority
- BE
- Belgium
- Prior art keywords
- compounds
- treatment
- bacterial infections
- infections
- bacterial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB15209/75A GB1545467A (en) | 1975-04-14 | 1975-04-14 | Deoxyclavulanic acid and deoxyisoclavulanic acid and derivatives thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BE840253A true BE840253A (fr) | 1976-09-30 |
Family
ID=10054957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE165741A BE840253A (fr) | 1975-04-14 | 1976-03-31 | Compose utilisables dans le traitement des infections bacteriennes |
Country Status (5)
Country | Link |
---|---|
BE (1) | BE840253A (fr) |
GB (1) | GB1545467A (fr) |
IN (1) | IN142091B (fr) |
ZA (1) | ZA761953B (fr) |
ZM (1) | ZM4076A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4123540A (en) | 1974-12-18 | 1978-10-31 | Beecham Group Limited | Isoclavulanic acid as an antibacterial and a β-lactamase inhibitor |
US4166904A (en) * | 1977-02-26 | 1979-09-04 | Beecham Group Limited | ⊕-lactam containing compounds |
-
1975
- 1975-04-14 GB GB15209/75A patent/GB1545467A/en not_active Expired
-
1976
- 1976-03-23 IN IN511/CAL/76A patent/IN142091B/en unknown
- 1976-03-25 ZM ZM40/76A patent/ZM4076A1/xx unknown
- 1976-03-31 BE BE165741A patent/BE840253A/fr unknown
- 1976-03-31 ZA ZA761953A patent/ZA761953B/xx unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4123540A (en) | 1974-12-18 | 1978-10-31 | Beecham Group Limited | Isoclavulanic acid as an antibacterial and a β-lactamase inhibitor |
US4166904A (en) * | 1977-02-26 | 1979-09-04 | Beecham Group Limited | ⊕-lactam containing compounds |
Also Published As
Publication number | Publication date |
---|---|
ZA761953B (en) | 1977-04-27 |
IN142091B (fr) | 1977-05-28 |
ZM4076A1 (en) | 1977-09-21 |
GB1545467A (en) | 1979-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2273509A1 (fr) | Article pour le traitement des menstrues | |
FR2338687A1 (fr) | Endoscope pour le traitement de strictions uretrales | |
IT1036563B (it) | Composizione per il trattamento ritaroato delle ferite apeerte contaminate | |
IT1062533B (it) | Composizione per il trattamento di tessuti | |
BE843359A (fr) | Preparation pour le traitement de parodontose | |
FR2299379A1 (fr) | Compositions de traitement de surface | |
BE828555A (fr) | Composition pour le traitement d'infections virales | |
FR2307909A1 (fr) | Compositions pour le traitement des etoffes | |
BE859851A (fr) | Traitement d'infections bacteriennes | |
BE793792A (fr) | Compositions pour le traitement de la peau | |
NL7607203A (nl) | Behandeling van mineralen. | |
BE811068A (fr) | Composition pour le traitement des cheveux | |
FR2306710A1 (fr) | Composition pour le traitement du colon | |
SE7609100L (sv) | Hudbehandlingskomposition | |
BE841018A (fr) | Conteneur de traitement | |
FR2342058A1 (fr) | Composition pour le traitement des cheveux | |
BE838614A (fr) | Agents pour le traitement des cheveux | |
IT1069108B (it) | Composizione per il trattamento di infezioni da funghi nel bestiame | |
BE840253A (fr) | Compose utilisables dans le traitement des infections bacteriennes | |
BE841614A (fr) | Traitement des animaux | |
FR2311553A1 (fr) | Medicament pour le traitement de la schizophrenie | |
IT1057861B (it) | Composizione per la diagnosi ed il trattamento di infezioni microbiche | |
SE389018B (sv) | Forfarande for framstellning av en komposition till anvendning vid behandling av urinvegsinfektioner orsakade av karbamidspjelkande bakterier | |
BE820222A (fr) | Composition therapeutique pour le traitement du diabete par voie orale | |
BE815825A (fr) | Composition pour le traitement de la peau |